National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

levofloxacin
A broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. Levofloxacin diffuses through the bacterial cell wall and acts by inhibiting DNA gyrase (bacterial topoisomerase II), an enzyme required for DNA replication, RNA transcription, and repair of bacterial DNA. Inhibition of DNA gyrase activity leads to blockage of bacterial cell growth. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand names:Levaquin
Quixin



Previous:levamisole hydrochloride, Levaquin, levetiracetam, levocarnitine, levodopa
Next:levonantradol, levonorgestrel, levonorgestrel-releasing intrauterine system, Levopa, levothyroxine sodium

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov